Alireza Faridar, M.D., a neurologist at Houston Methodist Hospital, looked at (PDF) the IL-2 component of the combination in an investigator-initiated trial. The study randomized 38 people with mild ...

PT101 is an engineered IL-2 mutein fused to a protein backbone ... that are trying to flip that on its head and try to use the cytokine to protect organs from autoimmune reactions.

Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.

Less frequent IV dosing with nemvaleukin in patients with select advanced solid tumors, including ovarian cancer and mucosal melanoma, showed ...

Werewolf Therapeutics (HOWL) shared clinical and preclinical data at the 2024 Society for Immunotherapy of Cancer’s 39th Annual Meeting, ...

1 V.A. Nasonova Research Institute of Rheumatology, laboratory of immunology and molecular biology rheumatic diseases, Moscow, Russian Federation 2 V.A. Nasonova Research Institute of Rheumatology, ...

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was ...

The lock-and-load flexibility of the FHAB platform offers the bifunctional payload capability of adding another synergistic ...